Sign In

2016 Spring Meeting Session Materials


Session Materials

Welcome to the 2016 AIPLA Spring Meeting session materials page. Papers are available to all registered attendees. If a speaker has submitted material, there will be a link(s) to their bio, paper, and slides next to their name.

A DVD with all the submitted session materials will be sent to all registrants about 6 weeks after the conference. We will also have audio available online about 6 weeks after the meeting.

To access the session handouts, please Sign-In by clicking "Sign In" in the upper right corner of this web page. If you are having any trouble accessing the session handouts, please send us an email or call 703.415.0780.

DownloadAllSessionMaterials ​​(updated 5/13/2016)



Wednesday, May 18


9:00 AM - 12:00 PM Concurrent Morning Tracks



Track 1: Patent Litigation



PT AB: Where Are We Now? A State of the Board, Including an Overview of the PT AB and District Court Decisions, PT AB Practice and Procedures, and Case Law Developing in Response to PT AB Proceedings







         Elizabeth Cowan Wright, Faegre Baker Daniels, inneapolis, MN




Ships Passing: An Overview of Potential Solutions to Inconsistencies Between


Decisions In District Court and the PT AB



          W. Todd Baker, Obion McClelland Maier and


          Neustadt, LLP, Alexandria, VA (Bio, Paper)




Rules of the Game: An Update on Practice and Procedures in PT AB



         Timothy Bianchi, Schwegman Lundberg Woessner. PA.


         Minneapolis, MN (Bio, Paper)




The Trickle Down Effect: Updates Surrounding Pending Litigation and Case


Law Stemming from PTAB Proceedings



          Rob Sterne, Sterne Kessler Goldstein Fox, Washington, DC​ (Bio, Paper)





10:15 - 10:45 AM      Networking Break




The New Biosimilars Pathway: Litigation Implications and Strategies for Biopharma and Biosimilar Companies

Moderator:                                                                                                                                                                     Krista Carter, Kaye Scholer, Palo Alto, CA (Bio, Paper)


 Biosimilars v. Branded Biologics and an In-House Perspective on Preparing for and Managing Biosimilars Litigation and PT AB Proceedings



         Leslie Robbins, Coherus BioSciences, Inc., Redwood City, CA (Bio)



 BPCIA Patent Dance: Preparations and Strategies for Disclosures


           Barbara Fiacco, Foley Hoag, LLP, Boston, MA(Bio, Paper)


 Recent Developments in Biosimilars Case Law and Their Implications


         Nick Groombridge, Paul Weiss, New York, NY (Bio)


 Claim Constructions for Biologics/ Biosimilars across District Court Litigation and other Contentious Proceedings, and Prosecution Strategies to Help Prepare for Those Proceedings


         Denise M. Kettelberger, Sunstein Kann Murphy & Timbers. LLP, Boston, MA (Bio)






Track 2: Patent Prosecution


  Not Your Granddaddy's Grace Period and Added Matter-Comparative Views in the US, Europe and China




           Enrica Bruno. Steinfl & Bruno, LLP, Pasadena CA (Bio)


 "Graceu Depends On Where You Are From. Grace Periods: A Comparative Report


          Paul Cole, Lucas & Co, Warlingham, United Kingdom( Bio, Paper, Slides)


 Is The EPO Softening Its Stance? Recent Developments In EPO Added Matter Practice


         Scott Harrison, Swindell & Pearson, Ltd., Derby,United Kingdom (Bio, Paper​)


 The Liberal West and the Conservative East: Different Standards For Added Matter


         Chris Scherer, Andrus Intellectual Prop erty Law, Milwaukee, WI(Bio,Paper)


         Stephen Yang, Chofn Intellectual Property, Beijing, China(Bio, Paper, Slides)




10:15 - 10:45 AM Networking Break​




Can This Patent Application Be Saved? 




         Elise Selinger, Conley Rose, PC, Plano, TX (​​Bio​)


The USPTO Has its Priorities Straight:The Restoration of Priority at the USPTO


        Carl Oppedahl, Oppedahl Patent Law Firm, LLC, Westminster, CO (Bio, Paper, Slides)


Updates from the Front: Electronics/Software


       Robert Sachs, Fenwick & West, San Francisco, CA(Bio)


Updates from the Front-BIO

        Suzannah K. Sundby, Canady & Lortz, Washington, DC (Bio, Paper)




T3 Tradema​rk/Copyright

Copyright: Hot Topics Related to the Internet, and Legal Reforms Internationally


       Bruce H. Little, Lindquist & Vennum, LLP,  Minneapolis, MN

 Copyright: Linking and Making Available on the Internet

         Kevin Tottis, TottisLaw, Chicago, IL(Bio,  Paper)

 Legal Reforms in the European Union and Implications of the Trans Pacific

Partnership (TPP)

         James Seadon, Fieldfisher, London, United Kingdom (Bio)

 Protecting Content Online: The Interface of Copyright and Designs for Websites, Apps, and GUIs

          Sara Anne Hook, Indiana University School of Informatics and Computing​(BioPaper)


10:15 - 10:45 AM Networking Break


Thou Shalt Not Offend ... The Continuing Saga Over Registration of Immoral and Scandalous Marks at the USPTO  How Did We Get Here? A Brief Legal History of "Scandalous and lmmoralu Marks Where Are We Headed?  (Or Have We Arrived?) An Overview of Recent Cases


        Joel G. MacMull, Archer & Greiner, PC, Hackensack, NJ (Bio, Paper)

        Stephen R. Baird, Winthorp & Weinstine, PA,MinneapolisMN​​ (Bio)



12:00 - 12:30 PM Lunch Reception (open to all attendees)


2:00 - 3:30 PM 

Concurrent Afternoon Tracks

Track 1: Trademark

Labeling, Advertising, and Branding Issues for Agriculture and Food: Trends In the Interplay Between Regulations and IP


         Kathleen Lemieux, Borden Ladner and Gervais,Ottawa, Ontario, Canada


          Patrick Kole, Idaho Potato Commission, Eagle, ID   (Bio, Paper​)

           Art MacCord, MacCord Mason, Greensboro, NC (Bio, Paper, Slides)



Track 2: corporate


         Sandy Block, IBM, Armonk, NY  

MAD in a GOOD Way: Merge/ Acquire/Divest with IP and Antitrust Regulation in Mind

          Michael L. Keeley, Axinn, Washington, DC(Bio)


 Juror Perceptions on Race and Gender:Making the Business Case for Diversity

         Johanna Carrane, JuryScope, Inc., Eden Prairie, MN (Bio, Paper,Slides)


Track 3:  Patent Licensing

License to Kill? How to Protect the Value of Your Patent Portfolio In Uncertain Times


         Randi Karpinia, Motorola Solutions, Inc., Hypoluxo, FL (Bio)

 ls it Time to Audit The Royals? Royalty Audits And Determining Whether You Are Extracting the Full Value of Your IP Portfolio

      Peter Ball, Mayo Clinic Ventures, Rochester, MN(Bio, Paper)

     Celene Blank, 3M Center, Saint Paul, MN (Bio)

 Exhausting All Possibilities - Why The Analysis for International Patent Exhaustion

Should be Different than that for Copyrights

       Jeremy McKown, Johnson & Johnson,  New Brunswick, NJ​(Bio, Paper)


3:30 - 5:30 PM

Committee Educational Sessions

C1: IP Practice in China/Patent Law

 (Joint Session) (90 Minutes of CLE Requested)


       David Resnick, Nixon Peabody, LLP, Boston, MA 

Medical Diagnostics: Patent Eligibility and Issues in the US and China

      Health and medicine is a growing market in the US and Internationally as our populations live longer. How can you protect medical diagnostics that involve sensing and collecting data? What are workarounds for getting these types of innovations protected both in the US and China? Come hear from inside and outside counsel onhow to best address these and other questions.


             Alana Bergman, Medtronic, Minneapolis, MN (Bio, Paper)

             Brian Dorn, Arthrex, Naples, FL (Bio, Paper)

             Jeffrey Stone, Barnes & Thornburg, Minneapolis, MN(Paper)

             Luke Zuo, NTD, Beijing, China (Bio, Paper)


C2: Biotechnology/Food and Drug

(Jomt Session) (120 Minutes of CLE Requested)


         Vicki G. Norton, Duane Morris, LLP, San Diego, CA (Bio​)

Mars 101-lnternational and Interplanetary Considerations for GMOs: Patents, Export control, Biodiversity and Regulation

     The panel will engage the audience in an interactive discussion of international IP and regulatory considerations for genetically modified organisms (GMOs), and will explore the fina l frontier of patent eligibility for GMOs on Mars. Experts on patents, export control, biodiversity and regulation will provide their insights into patent eligibility for GMOs, issues relating to FDA regulations for GMOs, and export control and biodiversity, including an update on WI PO's February 2016 meeting of the Intergovernmental Committee on Intellectual Property and Genetic Resources.


         Marian T. Flattery, DuPont Pioneer and DuPont Crop Protection, Johnston. lA​ (Bio)

         Debora Plehn-Dujowich, Prismatic Law Group, PLLC,Washington, DC(Slides)

         Kan Wang, Iowa State University, Ames, Iowa (Bio)

C3: Special Committee on Pro Bono
(120 Minutes of CLE Requested) Ethics CLE
           Angela Grayson, Walmart Stores, Inc., Bentonville, AR(Bio, Paper)
           Jay Erstling, Patterson Thuente IP, Minneapolis, MN ( Bio, Paper, Slides​)
Pro Bono: The Why and the How
    The session will explore some of the many reasons why IP practitioners engage in IPrelated pro bono activities, and it will look at a few of the pro bono options available, including the USPTO's pro bono and clinic certification programs. The topics covered by the speakers and panelists will include an overview of ethics issues involved in handling pro bono matters as well as some of the special considerations in working with pro bono clients. The keynote speaker will be an invited official from the USPTO's Midwest Office.
         Christal Sheppard, US Patent and Trademark Office (Bio)
         Elijah J. McCoy, Midwest Regional Office​.Detroit, Ml (invited)
         William Covey, US Patent and Trademark Office, Alexandria, VA (Invited)
         John Kirkpatrick, US Patent and Trademark Office, Alexandria, VA (invited)
            Victoria Phillips, American University Washington College of Law, Washington, DC (Bio, Paper )
            Gillian Rosenquist. Lega/CORPS Inventor Assistance Program, Minneapolis, MN (Bio)
            Bob Pimm, California Lawyers for the Arts, Berkeley, CA (Paper)
            Brett Klein, Winthrop and Weinstine, Minneapolis, MN (Bio, Paper)
            Daniel Bruzzone, Patterson Thuente IP, Minneapolis, MN 
            Michael Lopez, Brooklyn Center, MN 

3:30 – 5:30 PM Committee Meetings
Thursday, May 19
7:00 - 9:00 AM Committee Meetings*
8:00 AM - 5:30 PM
Registration, Exhibits, CLE Information and Membership Service Center,
9:00 AM - 12:00 PM
Concurrent Morning Tracks
T1: International
Moderator (both sessions):
         Dewayne Hughes, Drager, Telford, PA (Bio​)
Do's and Don't's for Oppositions in the us, Europe, and Japan
         Rick Nelfeld, Neifeld IP Law, PC, Alexandria, VA (Bio, Paper)
         Lucy Samuels, Gill Jennings & Every, LLP, London, United Kingdom (Bio, Paper)
         Kenji Yoshida, YKI Patent Attorneys, Tokyo, Japan (Bio, Paper, Slides)
10:15- 10:45 AM Networking Break
A Closer Look at Priority and PCT Filings Pitfalls and Traps for the Unwary
          Morten Garberg, Hoffmann Eitle, Munich, Germany (Bio, Paper, Slides)
          Shimako Kato. Abe. lkubo & Katayama, Tokyo, Japan (Bio, Paper, Slides)
           Marco M. Aleman, World Intellectual Property Organization, Geneva, Switzerland (Bio)
 T2: Trade Secret
A Guidebook to Effective Trade Secret Protection
      Rosemarie R. Wilk-Orescan, Novo Nordisk, Inc., Plainsboro, NJ
Strategies for Trade Secret Audits 
       Pamela Stewart, 3M Company, St. Paul, MN (Bio)
       Valerie Calloway, Alltech, Inc., Nicholasville, KY (Bio)
Reasonable Efforts to Protect Trade Secrets under the UTSA: A Survey of What Courts
are Requiring for Trade Secret Claims.
        Jeanne Gills, Foley & Lardner. LLP, Chicago, IL (Bio)
10:15 - 10:45 AM Networking Break
Trade Secret Protection in Today’s IP Landscape
         Rosemarie R. Wilk-Orescan. Novo Nordisk, Inc., Plainsboro, NJ
The Fallout for Life Science Patents and Trade Secrets from the Rtse of Section 101
         Warren Woessner, Schwegman Lundberg Woessner, Minneapolis, MN (Bio,Paper)

The Ethical DHemma Regarding Best Mode In Light of the AlA Reality vs. Theory
and the Implications for Trade Secret Protection Ethics CLE
         Louis F. Wagner, Hahn Loeser, Akron, OH (Bio​, Paper, Slides)

T3: Unauthorized Practice of Law and the Ethics of Cost Effective Patent
Prosecution and Trademark Practice Not a Lawyer, Is that a Problem? The Ethics and Business Considerations of Using Non-Lawyers In IP Practices
        Sharra Brockman, Verv, Minneapolis, MN ( Bio)
Straddling the Line: What Tasks can Non-Lawyers Perform?
          Jennifer Debrow. Gray Plant Mooty, Minneapolis, MN (Bio, Paper)
 Staying Competitive In the Market Using Trademark Paralegals
         Josh Burke, General Mills, ln·t.:" Minneapolis, MN (Paper)
         Elyssa Chayo, Firm Forward, LLC, Houston, TX (Paper)
10:15- 10:45 AM Networking Break
        James Bell, Cabinet Beau de Lomenie, Paris, France​ (Bio)​
Protecting Privilege: Patent Agents within the Bar.
        Anthony Tridico, Finnegan, London, UK(Bio, Paper, Slides)
Leveraging Experience and lower Bill Rates: Patent Agents In Patent Prosecution
      Angie Sebor, Globelmmune, Inc., Louisville, CO (Bio)
      Joshua Burke, General Mills, Inc., St. Paul, MN (Bio)

10:00 - 11:00 AM Education Task Force (Committee Members Only)
12:00 - 12:30 PM Lunch Reception (open to all attendees)
12:30 - 2:00 PM Luncheon
   Featured Speaker:
            James Smith, Chief IP Counsel for Law & Regulatory Affairs, Ecolab USA, St. Paul, MN (Bio​)
2:00 - 3:30 PM
Concurrent Afternoon Tracks
T1: Litigation
The New Era of Patent Litigation: Recent Developments in Damages and Discovery
        Kristine M. Boylan, Briggs and Morgan, Minneapolis, MN (Bio)
 Uniformity In E-Discovery Obligations and Sanctions After Recent Amendments to the Federal Rules
        Robert Counihan, White & Case, New York, NY (Bio, Paper, Slides)
 The Practicalities of Proving Patent Damages Given Changes in Case law
        Blake Inglish, Berkeley Research Group, San Diego, CA ​( Bio, Paper, Slides)
Trends In Willfulness and Fee Petitions
        Rudy Telscher, Harness, Dickey & Pierce, PLC, Clayton,MO (Bio, Paper, Slides)
T2: Copyright
The Fair Use Defense - Is It Fair?
          Craig Whitney, Frankfurt Kurnit Klein & Selz, PC, New York, NY​ (Bio)
In Theory: What Fair Use Was Meant to Be 
          Tom Cotter,Briggs and Morgan University ofMinnesota Law School, Minneapolis, MN 
          (Bio , Paper, Slides)
In Practice: Where Courts Have Taken Fair Use
         Sarah A. Howes. Copyright Alliance, Washington. DC(Bio, Paper)
In the Future: Whither Fair Use Guidelines
        Jon M. Garon, Nova Southeastern University, ShepardBroad College of Law, Fort Lauderdale, FL      
        (Bio, Paper​)

T3: Patent Litigation: Sinking Ships and Rising Seas
       Jennifer Librach Nall, Baker Botts, LLP, Austin, TX(Bio)
Discussion of the Current State of Patent Litigation, Including the Magnitude and Roots Causes of Recent Litigation Trends, Technical Areas of Impact, and Effects on Patent Assertion Entities
       John C. Adkisson, Fish & Richardson, PC, Minneapolis, MN(Bio , Paper)
An Evaluation of the Extent to Which Recent Trends In Patent Litigation are a Product of Public Policy, How They May Shape Future Public Policy, and Whether the Trends will Further the Ability of the US Patent System to Promote Progress of Science and the Useful Arts
         David J. Kappos. Cravath, Swaine & Moore, LLP, New York, NY (Bio, Paper1, Paper2 )
Discussion of the Effects of the AlA on Business, Whether the AlA has resolved Business Challenges Presented by Patent Assertion Entitles, and Whether Future Policy Changes will be In the Form of Patent Reform Legislation, USPTO Policy Change, or Judicial Action
        Kevin H. Rhodes, 3M Innovative Properties Company, St. Paul, MN(Bio, Paper​)

3:30 - 5:30 PM Committee Educational Sessions

C1 Licensing and Management of IP Assets/Standards and Open Source  (120 Minutes of CLE Requested)
Open Source Is Here to Stay: How Your Client Can Leverage Open Source Software and the Open Source Community Without Losing Its IP Rights.
        Cindy Huang, Carter DeLuca Farrell & Schmidt, LLP, Melville, NY(Bio)
    Your clients are probably using open source software (even if they think they aren’t), so it is important to understand its implications. Browsers, security software, databases on the cloud - even snippets of code developers slip into product software. or application programming interfaces - could be open source! Our three panelists will address topics geared toward adv1sing not only large company enterprises but also small companies and start-ups. The first panelist will discuss the value of proprietary code that includes open source software and how to safely incorporate and distribute open source licensed software without negatively Impacting the company and IP. The second panelist will take a deep dive into open source licenses and their potential impact on a company's patent portfolio, including a discussion of express and implied patent licenses. Finally, the third panelist will provide practical tips for any company that is considering contributing to or starting its own open source project, including how such a project can generate value for a company.
          Michael Atlass, Qualcomm. Inc .. San Diego, CA (Bio, Paper)
          Terry Ilardi, IBM Corporation, Armonk. NY (Bio, Paper​)
          Joanne Montague, Davis Wright Tremaine, LLP,Seattle, WA(Bio, Paper, Slides​)

C2: Corporate Practice/ Trade Secret Law Ethical CLE
(Joint Session) (120 Minutes of CLE Requested)
Ethics of Competitive Intelligence, Monitoring Employees and Restrictive Covenants Against In House Counsel
Spy v. Spy: The Ethics of Competitive Intelligence and Where to Draw the Line The Eye In the Sky: The Tools and Ethics of Monitoring Your Employees for Security Breaches
In-House Counsel, Whistleblowers and Restrictive Covenants: How Far Can anEmployer Ethically Restrict its Former In-House Counsel?
        Russell Beck, Beck Reed Riden, LLP, Boston, MA (Bio​)
       John Andersen, Ph.D .• Eft Lilly and Company,Indianapolis, IN 
       Randall E. Kahnke, Faegre Baker Daniels LLP,Minneapolis, MN (Bio, Paper, Slides)
       Barry Brown, Charles Schwab & Co., Inc., San Francisco. CA 
       Andrea Michelle Castetter, Eli Lilly and Company,Indianapolis, IN 

C3: IP Practice in Latin America/Patent

   Cooperation Treaty Issues

(Joint Session) (120 Minutes of CLE Requested)

Moderator and Coordinators:

         Brooke Schumm, Daneker Mcintire Schumm Prince Manning & Widmann, PC, Baltimore, MD                                 (Bio, Paper, Slides)

      Carl Oppedahl, Oppedahl Patent Law Firm, LLC, Westminster, CO (Bio, Paper, Slides​)

      The committee will broadly cover the international patent waterfront first featuring; an European Patent Office (EPO), speaker to discuss developments in the EPO, the Unified Patent, the Unified Patent Court, and the PACE accelerated exam program. Second, a speaker from WIPO will discuss developments at WIPO and with our EPO speaker, have a roundtable with our audience to discuss hypotheticals concerning intricate priority under the PCT,the more recent Patent Law treaty, and other priority treaties, and issues related to non- PCT countries. Third. in light of recent political developments in Argentina, a local attorney will discuss fi ling issues and practice issues in Argentina. We have a speaker from Peru and he will discuss enerally the "new Guidelines" approved by Mercosur countries on examination of chemical-pharaceutical patents. We will briefly discuss Cuba: a new jurisdiction where US practitioners may have to give attention. Finally we will discuss where Global Dossier is now and where it is headed.


          Marco M. Aleman, World Intellectual PropertyOrganization, Geneva, Switzerland (Bio )    

          Ignacio Sanchez Echague, Marva! O'Farrell & Mairal,Buenos Aires, Argentina (Paper)​

          Christof Matthoi, European Patent Office,Munich, Germany(Bio)

          Eugenio Perez Perez, Uhthoff Gomez Vegas & Uthoff. SC, Hamburgo, Mexico (Bio)

          Gisella Barredo, BRDA Abagados, Lima Per(Bio, Paper​)